February 6, 2020
Janssen Pharmaceutical and Mitsubishi Tanabe Pharma said on February 5 that they will expand the scope of the existing copromotion deal for Stelara (ustekinumab), an anti-IL-12/23 p40 monoclonal antibody, in Japan to include an indication of ulcerative colitis, for which...read more